Ocugen Inc
NASDAQ:OCGN

Watchlist Manager
Ocugen Inc Logo
Ocugen Inc
NASDAQ:OCGN
Watchlist
Price: 1.13 USD -5.83% Market Closed
Market Cap: 330m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

OCGN Price Targets Summary
Ocugen Inc

Wall Street analysts forecast OCGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCGN is 6.63 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

OCGN Lowest Forecast
Wall Street Target
4.04 USD
258% Upside
OCGN Average Forecast
Wall Street Target
6.63 USD
487% Upside
OCGN Highest Forecast
Wall Street Target
8.4 USD
643% Upside
Lowest
Price Target
4.04 USD
258% Upside
Average
Price Target
6.63 USD
487% Upside
Highest
Price Target
8.4 USD
643% Upside
Ocugen Inc Competitors:
Price Targets
B
BCAX
Bicara Therapeutics Inc
207% Upside
AGIO
Agios Pharmaceuticals Inc
63% Upside
87S
Roivant Sciences Ltd
60% Upside
SNDX
Syndax Pharmaceuticals Inc
251% Upside
B
BCAX
Bicara Therapeutics Inc
207% Upside
AGIO
Agios Pharmaceuticals Inc
63% Upside
87S
Roivant Sciences Ltd
60% Upside
SNDX
Syndax Pharmaceuticals Inc
251% Upside
GILD
Gilead Sciences Inc
7% Upside
CSL
CSL Ltd
35% Upside
M
GLUE
Monte Rosa Therapeutics Inc
236% Upside
LEGN
Legend Biotech Corp
112% Upside

Revenue
Forecast

Revenue Estimate
Ocugen Inc

For the last 12 years the compound annual growth rate for Ocugen Inc's revenue is 51%. The projected CAGR for the next 3 years is 200%.

51%
Past Growth
200%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ocugen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ocugen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-81%
Average Miss
What are analyst estimates?

See Also

Summary
OCGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
OCGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OCGN stock valuation using valuation multiples.
Wall Street Estimates
OCGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OCGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCGN's stock price target?
Price Target
6.63 USD

According to Wall Street analysts, the average 1-year price target for OCGN is 6.63 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

What is Ocugen Inc's Revenue forecast?
Projected CAGR
200%

For the last 12 years the compound annual growth rate for Ocugen Inc's revenue is 51%. The projected CAGR for the next 3 years is 200%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.